知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Zhang, Yunfeng 西安交通大学被知名学者引用:131人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 詹启敏 中国 北京大学 中国工程院院士 A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesopha..

2. Yuji,Toiyama 日本 Mie University Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esopha..

3. Liu,Hsiao-Sheng 中国 台湾国立成功大学 Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lu..

4. 叶汉根 中国 长庚大学 Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lu..

5. Khawla S,Al-Kuraya 沙特阿拉伯 King Faisal Specialist Hospital & Research Center PLK1 and PARP positively correlate in Middle Eastern breast cancer and their combined inhibition ove..

6. 毛传斌 中国 浙江大学 A nanoparticle-based molecular beacon for directly detecting attomolar small RNA from plasma without..

7. Kato, Ken 日本 National Cancer Center - Japan Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

8. Koji,Kono 日本 Fukushima Medical University Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

9. Hiroya,Takeuchi 日本 Hamamatsu University School of Medicine Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

10. Manabu,Muto 日本 Kyoto University Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1

11. Manish A,Shah 美国 Cornell University Improving outcomes in patients with oesophageal cancer

12. Nasser K,Altorki 美国 New York Presbyterian Hospital Improving outcomes in patients with oesophageal cancer

13. Adam J,Bass 美国 Harvard University Improving outcomes in patients with oesophageal cancer

14. 彭成 中国 成都中医药大学 Update on the sources, pharmacokinetics, pharmacological action, and clinical application of anisoda..

15. Srinivasan,Madhusudan 英国 University of Nottingham Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer

16. Emad A,Rakha 英国 University of Nottingham Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer

17. 黄灿华 中国 四川大学 Protein degradation: expanding the toolbox to restrain cancer drug resistance

18. Benjamin,Bonavida 美国 University of California Los Angeles Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability

19. 赵霞 中国 四川大学 Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed

20. Frank,Schneider 德国 RWTH Aachen University Multiplexed protein profiling reveals spatial subcellular signaling networks

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3